Etiqueta: stem cell treatments
-
Osiris Demonstrates Exceptional Performance of Adult Stem Cell Product in Clinical Trial
The adult stem cell company Osiris Therapeutics has announced its final set of two-year results from its clinical trial for Prochymal, one of its adult stem cell products, which has met and surpassed all performance expectations.
-
Multiple Sclerosis Successfully Treated Yet Again With Adult Stem Cells
Researchers at Northwestern University have once again achieved encouraging results in the treatment of multiple sclerosis with adult stem cells.
-
The Stem Cell Revolution
In a highly biased and inaccurately distorted report, Time Magazine once again features stem cells as a cover story.
-
Multiple Sclerosis Patients Improve After Adult Stem Cell Therapy
Doctors in Chicago use adult stem cells derived from bone marrow to halt and reverse the progression of multiple sclerosis.
-
Neuralstem Receives Patent for Neural Stem Cell Immortalization Technology
The company Neuralstem has been awarded a patent for its proprietary technology to immortalize human neural stem cells.
-
FDA Approves First Human Embryonic Stem Cell Trial
The biotech company Geron has received FDA approval to conduct the first human clinical trial with embryonic stem cells.
-
Mesoblast Announces Approval of First Osteoarthritis Clinical Trial Utilizing Adult Stem Cells
The Australia-based company Mesoblast Limited announces institutional approval to begin the first human clinical trials of adult stem cell treatment for the prevention of osteoarthritis in the knee after acute traumatic injury.
-
Opexa Briefs Shareholders on Corporate Update
Opexa Therapeutics holds an informative briefing on both executive and scientific company news.
-
Cardiac Dysfunction Secondary to Diabetes is Treated with Adult Stem Cells
Scientists in Egypt demonstrate the ability of bone marrow stem cells to treat chronic cardiac disease that is associated with diabetes.
-
Pluristem to Begin Adult Stem Cell Clinical Trials for Critical Limb Ischemia
Pluristem Therapeutics has announced filing of applications with both the U.S. and European regulatory agencies to initiate clinical trials in the treatment of critical limb ischemia with adult stem cells.